Observation Versus Immediate Surgery of Low Risk Bladder Cancer
NCT02700724 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2018-08-13
Summary
This trial is a randomized, multi-center, non-inferiority study comparing observation versus immediate surgery for low grade, noninvasive bladder cancer.
Conditions
Interventions
- OTHER
-
Immediate Surgery
- OTHER
-
Observation
- PROCEDURE
-
Surveillance Cystoscopy and Urinary Cytology
Cytology and cystoscopy are done at the same time
Sponsors & Collaborators
-
Vanderbilt University Medical Center
lead OTHER
Principal Investigators
-
Daniel D. Lee, MD · Vanderbilt University Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2018-07-19
- Completion
- 2018-07-19
Countries
- United States
Study Locations
More Related Trials
-
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
NCT04688931 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer
NCT02143804 ·Status: WITHDRAWN ·Phase: PHASE2
-
Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
NCT00003640 ·Status: TERMINATED ·Phase: PHASE2
-
Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder
NCT02745301 ·Status: COMPLETED
-
A Diagnostic for the Early Detection of Bladder Cancer
NCT05347342 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)
NCT06211764 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Recurrence of Bladder Cancer After Transurethral Resection With Hexvix
NCT00785694 ·Status: WITHDRAWN ·Phase: PHASE4
-
Unmet Supportive Care Needs in Bladder Cancer Patients Undergoing Radical Cystectomy
NCT03307200 ·Status: COMPLETED
-
Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging
NCT02203136 ·Status: COMPLETED
-
A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)
NCT01314664 ·Status: TERMINATED
-
The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression
NCT04617743 ·Status: UNKNOWN
-
Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade
NCT02992990 ·Status: UNKNOWN ·Phase: NA
-
A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing
NCT07036731 ·Status: RECRUITING ·Phase: NA
-
Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)
NCT02710734 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)
NCT05136898 ·Status: COMPLETED ·Phase: PHASE3
-
sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer
NCT02767921 ·Status: TERMINATED ·Phase: PHASE1
-
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
NCT06986304 ·Status: RECRUITING
-
Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder
NCT02202772 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
NCT06350734 ·Status: ACTIVE_NOT_RECRUITING
-
The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients
NCT06245759 ·Status: RECRUITING
-
Study of Combined VisioCyt Test and FGFR3 Mutations on a Urinary Sample to Diagnose Bladder Tumors
NCT05151341 ·Status: COMPLETED ·Phase: NA
-
Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer
NCT00003642 ·Status: TERMINATED ·Phase: PHASE2
-
Surgery and BCG in Treating Patients With Bladder Cancer
NCT00002990 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Multicentric Evaluation of a Bladder Preservation Strategy
NCT01093066 ·Status: TERMINATED ·Phase: PHASE2
-
Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder
NCT02968732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA